-
Bifendate Inhibits Autophagy at Multiple Steps
2026-09-21
The reference study identifies Bifendate (DDB) as a multi-step autophagy inhibitor rather than a compound that simply changes autophagy marker abundance. Using cell-based lysosomal and lipid-accumulation models, the authors show that DDB interferes with autophagosome–lysosome fusion, lysosomal acidification, and autophagic lysosome reformation while reducing oleic acid-induced lipid droplets.
-
VE-821: Selective ATR Kinase Inhibitor Guide
2026-09-21
VE-821 is an ATP-competitive ATR kinase inhibitor for DNA damage response inhibitor studies, radiosensitization assays, and chemotherapy sensitization research. Vendor-reported biochemical potency and cellular findings support its use as a controlled in vitro tool, while the available evidence does not establish clinical or antiviral efficacy.
-
Berberrubine chloride: Research Workflows
2026-09-20
Berberrubine chloride supports mechanism-led studies spanning colorectal cancer, NSCLC chemosensitization, urate transport, and enzyme-mediated drug interaction research. This workflow-focused guide covers DMSO preparation, cell and enzyme assay design, reference-study translation, and troubleshooting for more reproducible results.
-
Cotton Gland Size and Phytoalexin Feedback
2026-09-19
The reference study identifies a GoPGF–JAVL negative feedback loop that coordinates cotton pigment-gland development, jasmonate homeostasis, and phytoalexin biosynthesis. Its findings suggest that tuning the relative activity of a positive transcriptional regulator and a VQ-domain protein may improve defense while avoiding uncontrolled metabolic activation.
-
Transcription Termination Limits WEE1-Inhibitor DNA Damage
2026-09-18
A 2026 Nucleic Acids Research study shows that transcription termination protects replicating cells from DNA damage caused by WEE1 inhibition. Genetic depletion and pharmacological perturbation identify read-through transcription and transcription–replication conflicts as actionable determinants of cancer-cell survival.
-
Ceruletide for Reliable Pancreatic Assays
2026-09-18
Learn how Ceruletide (SKU B8465) can support reproducible pancreatic function research, gastrointestinal physiology studies, and receptor-driven cell assays. This scenario-based guide covers assay compatibility, formulation, interpretation, and practical supplier selection without confusing a biological stimulus with a viability reagent.
-
Chloroquine BA1002 for Reliable Cell Assays
2026-09-17
This scenario-driven guide explains how Chloroquine (SKU BA1002) can support reproducible cell viability, proliferation, and cytotoxicity workflows. It covers lysosomal mechanism, solvent compatibility, dose selection, endpoint interpretation, and practical supplier-selection criteria.
-
3-Hydroxybutyrate (BHBA) in Ferroptosis Workflows
2026-09-17
Use 3-hydroxybutyrate (BHBA) to model ketone-driven metabolic adaptation while connecting energy status with ferroptosis and chromatin regulation. This workflow translates stroke research into practical cell-based assays with defined dosing, orthogonal readouts, and troubleshooting controls.
-
Paroxetine Mesylate in Cardiac Biomarker Research
2026-09-16
Use Paroxetine Mesylate as a controlled pharmacology probe for separating serotonergic, enzyme, kinase, and cardiac biomarker effects. This workflow connects paired EEG–ECG analysis in epileptic baboons with cell-based and colorectal cancer assays while clearly distinguishing evidence-backed findings from exploratory applications.
-
LY2109761: TGF-β Signaling Workflow Guide
2026-09-15
LY2109761 enables mechanism-focused studies of TGF-β-driven Smad signaling, EMT, invasion, fibrosis, and radiation response. This workflow guide shows how to pair pathway inhibition with phosphoprotein, migration, stemness, and clonogenic assays while avoiding common interpretation and formulation errors.
-
Entinostat (MS-275): HDAC1/3 Research Guide
2026-09-15
Entinostat, also called MS-275 and SNDX-275, is an orally available class I HDAC inhibitor with stronger reported activity toward HDAC1 and HDAC3 than HDAC8. Its cancer research applications include epigenetic control of proliferation, retinoblastoma treatment research, and translational evaluation in solid tumor clinical trials.
-
Adipose-Neural Axis in Cardiac Arrhythmia
2026-09-14
Fan et al. developed a stem cell-based coculture model showing how epicardial adipose tissue can communicate with sympathetic neurons and cardiomyocytes through a leptin–NPY–Y1R pathway. The work identifies NCX and CaMKII as downstream effectors and provides a useful framework for distinguishing established Y1R mechanisms from hypothesis-generating studies of other NPY receptors.
-
Phosbind Acrylamide: Read Phosphorylation Logic
2026-09-14
Phosbind Acrylamide enables antibody-free protein phosphorylation analysis by resolving phosphate-dependent mobility shifts in SDS-PAGE. This guide connects the assay mechanism to bacterial signaling research and explains how to design controls, interpret results, and avoid overclaiming phosphorylation data.
-
Galectin-1, FIP200, and Hepatic Steatosis
2026-09-13
The 2026 reference study identifies a Galectin-1–FIP200 interaction as an upstream mechanism linking impaired autophagy with hepatic steatosis, dyslipidemia, and insulin resistance. Its combination of mouse gain-of-function experiments, proteomic analysis, interaction mapping, and mutation-based validation provides a mechanistic framework for studying metabolic dysfunction and for designing complementary glucose-uptake measurements.
-
Aneugen Mechanisms: Insights From 27 Reference Chemicals
2026-09-12
Bernacki and colleagues developed a tiered flow-cytometric strategy that detects chemical-induced genotoxicity and distinguishes major aneugenic mechanisms involving tubulin or mitotic kinases. The study shows how fluorescent Taxol responses, phospho-histone H3 to Ki-67 ratios, clustering, and machine learning can improve mechanism-oriented interpretation beyond a simple micronucleus-positive result.